ACT

JANUARY 22/2019


Advertisement

news roundup

Turnover Within CRO Companies Remains Persistently High

CRO companies are battling high turnover levels, but a new report from BDO USA, LLP, finds that compensation strategies generally have not made enough adjustments to their compensation strategy to address this on going issue. This report examines compensation and benefits trends in the CRO industry over the last 10 years, with a special focus on clinical research associates.

Advertisement

Tell us what you think about clinical operations and receive a $5 Amazon gift card!
Take the short survey


Elligo Health Research Acquires Protenium Clinical Research

Elligo Health Research, an integrated research organization, has acquired Protenium Clinical Research, an established research group led by Robert Strzinek, Ph.D., D.O. which conducts pharmaceutical studies in a broad range of therapeutic areas. The acquisition will bring the number of patients in Elligo's Research Ready network to more than one million.


Advertisement

Introducing Cross-Trial LMS: A Simple, Efficient, and Intuitive Way to Send Bulk Training
On Demand
Read More


Allscripts Collaborates with Microsoft to Explore Technology for Clinical Research

Allscripts, a provider of healthcare information technology solutions, announced a collaboration with Microsoft focused on implementing an integrated model for clinical research, in hopes to enhance clinical research design, conduct studies more efficiently, and improve the research provider and participant experience.


Quanticate Launches Pharmacovigilance Business

Quanticate, a global data-focused CRO has launched QVigilance to provide dedicated pharmacovigilance and risk management services. QVigilance will be focused on supporting small and mid-size companies transitioning from clinical trials to post-marketing and establishing compliant PV systems.


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »

advertisement

In this edition

Elligo Health Research Acquires Protenium Clinical Research
Data Dilemmas in Clinical Trials Continue
Patient Centricity: Improving Study Outcomes in Small Pharma
Testing the RBM Waters–A Global Midsize Sponsor Weighs the Benefits of RBM Implementation
advertisement

Events

14th Biosimilars Summit (Today & Tomorrow)
Clinical Data Disclosure and Transparency
Patient Registries and Real-World Evidence Summit
DIA Europe 2019
Search Upcoming Events

Articles

Leveraging Technology to Develop New Trial Endpoints

Outlining the potential of three mHealth technology approaches in enabling novel and more robust clinical outcomes measurements.


Data Dilemmas in Clinical Trials Continue

Survey uncovers key findings amid today's explosion of data volume and sources–and the added complexity in managing clinical data.


Blog Posts

Patient Centricity: Improving Study Outcomes in Small Pharma

In this interview, Rashieda Gluck, Senior VP, Global Clinical Operations, at Aurinia Pharmaceuticals, will discuss how patient centricity techniques are benefiting smaller biopharmaceutical companies.


How to Transition RWE Studies from Non-Clinical to Regulatory-Grade

The FDA has been working to enable greater adoption of RWE in clinical and regulatory decisions, as mandated by the 21st Century Cures Act.


RBM

Testing the RBM Waters–A Global Midsize Sponsor Weighs the Benefits of RBM Implementation

Risk-based approaches to monitoring (RBM) have become widely accepted in the clinical trials industry.


How Risk Based Monitoring is Changing Organizational Landscapes

RBM is an emerging area which gives endless opportunities to explore, transform, and evolve.


Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com